ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 249 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $20,678,000 | +16.1% | 1,263,930 | 0.0% | 1.16% | +3.1% |
| Q2 2022 | $17,809,000 | -41.8% | 1,263,930 | 0.0% | 1.13% | -28.2% |
| Q1 2022 | $30,574,000 | +608.1% | 1,263,930 | +583.2% | 1.57% | +835.1% |
| Q4 2021 | $4,318,000 | -71.7% | 185,000 | -50.0% | 0.17% | -68.1% |
| Q3 2020 | $15,263,000 | -14.9% | 370,000 | 0.0% | 0.53% | -33.1% |
| Q2 2020 | $17,934,000 | +14.7% | 370,000 | 0.0% | 0.79% | -26.0% |
| Q1 2020 | $15,633,000 | – | 370,000 | – | 1.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 563,200 | $16,243,000 | 9.48% |
| Avoro Capital Advisors LLC | 1,486,460 | $42,870,000 | 8.66% |
| Baker Brothers Advisors | 25,819,768 | $744,642,000 | 7.30% |
| SECTORAL ASSET MANAGEMENT INC | 1,176,543 | $33,932,000 | 3.76% |
| HARVEY CAPITAL MANAGEMENT INC | 251,825 | $7,262,000 | 3.38% |
| ACUTA CAPITAL PARTNERS, LLC | 300,000 | $8,652,000 | 3.22% |
| Palo Alto Investors LP | 1,532,030 | $44,184,000 | 2.52% |
| Ghost Tree Capital, LLC | 350,000 | $10,094,000 | 2.43% |
| EMORY UNIVERSITY | 76,121 | $2,195,000 | 2.16% |
| WEATHERBIE CAPITAL, LLC | 576,784 | $16,634,000 | 2.09% |